NO20005483L - Ny sammensetning - Google Patents

Ny sammensetning

Info

Publication number
NO20005483L
NO20005483L NO20005483A NO20005483A NO20005483L NO 20005483 L NO20005483 L NO 20005483L NO 20005483 A NO20005483 A NO 20005483A NO 20005483 A NO20005483 A NO 20005483A NO 20005483 L NO20005483 L NO 20005483L
Authority
NO
Norway
Prior art keywords
new composition
composition
new
Prior art date
Application number
NO20005483A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005483D0 (no
Inventor
Claude Artois
Michael J Clark
Clothilde Thiriart
Stefan Gabriel Jozef Thoelen
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of NO20005483D0 publication Critical patent/NO20005483D0/no
Publication of NO20005483L publication Critical patent/NO20005483L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • A61K39/292Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32411Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20005483A 1998-05-01 2000-10-31 Ny sammensetning NO20005483L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809507.8A GB9809507D0 (en) 1998-05-01 1998-05-01 Novel composition
PCT/EP1999/003024 WO1999056772A2 (en) 1998-05-01 1999-04-27 Hepatitis vaccine

Publications (2)

Publication Number Publication Date
NO20005483D0 NO20005483D0 (no) 2000-10-31
NO20005483L true NO20005483L (no) 2000-12-08

Family

ID=10831426

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005483A NO20005483L (no) 1998-05-01 2000-10-31 Ny sammensetning

Country Status (29)

Country Link
EP (1) EP1073462B1 (de)
JP (2) JP5138843B2 (de)
KR (1) KR100612547B1 (de)
CN (1) CN1263509C (de)
AR (1) AR016987A1 (de)
AT (1) ATE345815T1 (de)
AU (1) AU743759B2 (de)
BR (1) BR9910157A (de)
CA (1) CA2331086C (de)
CO (1) CO5050367A1 (de)
CY (1) CY1107322T1 (de)
CZ (1) CZ301232B6 (de)
DE (1) DE69934108T2 (de)
DK (1) DK1073462T3 (de)
ES (1) ES2277437T3 (de)
GB (1) GB9809507D0 (de)
GC (1) GC0000101A (de)
HK (1) HK1034202A1 (de)
HU (1) HU228209B1 (de)
IL (1) IL139269A0 (de)
MY (1) MY128929A (de)
NO (1) NO20005483L (de)
NZ (1) NZ507902A (de)
PL (1) PL190729B1 (de)
PT (1) PT1073462E (de)
TR (1) TR200003235T2 (de)
TW (1) TW553744B (de)
WO (1) WO1999056772A2 (de)
ZA (1) ZA200006118B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1513555A (zh) * 2003-07-31 2004-07-21 长春生物制品研究所 甲-乙型肝炎联合疫苗及其冻干制剂
EP1862176A1 (de) * 2006-05-31 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) * 2006-06-01 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
CN102198270B (zh) * 2011-05-16 2012-06-27 大连汉信生物制药有限公司 一种含铝佐剂乙肝疫苗的制备方法
KR101281098B1 (ko) * 2011-06-30 2013-07-02 주식회사 녹십자 B형 간염 바이러스 표면 항원상의 에피토프 및 이의 용도
CN102988975A (zh) * 2012-11-30 2013-03-27 深圳康泰生物制品股份有限公司 甲型、乙型肝炎联合疫苗及其制备方法
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0349686A (ja) * 1989-07-11 1991-03-04 Smithkline Biologicals Sa レトロウイルスgag蛋白の真核生物細胞における発現
ES2118963T3 (es) * 1992-05-23 1998-10-01 Smithkline Beecham Biolog Vacunas combinadas, que contienen antigeno de superficie de la hepatitis b y otros antigenos.
GB9503863D0 (en) * 1995-02-25 1995-04-19 Smithkline Beecham Biolog Vaccine compositions
JP4229341B2 (ja) * 1996-03-23 2009-02-25 財団法人阪大微生物病研究会 破傷風毒素の機能的フラグメント抗原及び破傷風ワクチン

Also Published As

Publication number Publication date
JP2010209118A (ja) 2010-09-24
HUP0101652A3 (en) 2004-10-28
NZ507902A (en) 2002-03-28
CZ20004061A3 (cs) 2001-04-11
CA2331086C (en) 2010-06-22
CN1308547A (zh) 2001-08-15
HK1034202A1 (en) 2001-10-19
TR200003235T2 (tr) 2001-03-21
HU228209B1 (en) 2013-01-28
HUP0101652A1 (hu) 2001-09-28
CY1107322T1 (el) 2012-11-21
MY128929A (en) 2007-02-28
GB9809507D0 (en) 1998-07-01
WO1999056772A3 (en) 2000-02-03
KR20010043224A (ko) 2001-05-25
ZA200006118B (en) 2002-01-30
JP2002513771A (ja) 2002-05-14
BR9910157A (pt) 2001-01-09
CZ301232B6 (cs) 2009-12-16
CA2331086A1 (en) 1999-11-11
AU4137999A (en) 1999-11-23
ATE345815T1 (de) 2006-12-15
GC0000101A (en) 2005-06-29
TW553744B (en) 2003-09-21
DE69934108T2 (de) 2007-04-19
PL190729B1 (pl) 2005-12-30
PT1073462E (pt) 2007-01-31
DK1073462T3 (da) 2007-02-26
AU743759B2 (en) 2002-02-07
JP5138843B2 (ja) 2013-02-06
DE69934108D1 (de) 2007-01-04
EP1073462A2 (de) 2001-02-07
ES2277437T3 (es) 2007-07-01
PL344137A1 (en) 2001-10-08
CN1263509C (zh) 2006-07-12
AR016987A1 (es) 2001-08-01
CO5050367A1 (es) 2001-06-27
IL139269A0 (en) 2001-11-25
EP1073462B1 (de) 2006-11-22
WO1999056772A2 (en) 1999-11-11
KR100612547B1 (ko) 2006-08-11
NO20005483D0 (no) 2000-10-31

Similar Documents

Publication Publication Date Title
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
NO20021116D0 (no) Ny sammensetning
ID29430A (id) Komposisi herbisida
ID26926A (id) Komposisi shampo pembentuk mode
ID26549A (id) Komposisi-komposisi epotilon
ATE367793T1 (de) Schweisshemmende zusammensetzungen
NO20005503L (no) Ny anvendelse
IS5430A (is) Ný samsetning
DE69919953D1 (de) Funktionelle zusammensetzungen
ATE469550T1 (de) Antiparasitäre zusammensetzungen
NO20021115D0 (no) Ny sammensetning
NO991944D0 (no) Ny forbindelse
DE69935172D1 (de) Imidosilan Zusammensetzungen
DE69942892D1 (de) Gaserzeugende zusammensetzung
ID23458A (id) Bentuk sediaan nefazodon
DE69928862D1 (de) Zusammensetzung
DE69902473T2 (de) Kosmetikzusammensetzung
ID26370A (id) Komposisi pengkondisian rambut
NO20003996L (no) Ny forbindelse
ID27889A (id) Komposisi-komposisi kopolimer polisiklik
ID29134A (id) Komposisi penataan rambut
DK0969233T3 (da) Strömningsbegrænser
DK199901730A (da) Ny Sammensætning
ID26295A (id) Komposisi keras-ultraviolet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application